Food and Drug Administration

Food and Drug Administration

The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency's work...

The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency's work affects Americans' health and safety.

Guests

Marc Kaufman

reporter on the national desk of "The Washington Post"

Dr. Jerry Avorn

author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston

Alan Goldhammer, PhD

associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)

Sen. Charles Grassley

(R-Iowa), ranking member of the Senate Finance Committee

Dr. Sandra Kweder

deputy director of the FDA's Office of New Drugs

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.